27EC Rostami, Abdolmohamad - Thomas Jefferson University - Thomas Jefferson University
Abdolmohamad Rostami, MD, PhD

Abdolmohamad Rostami, MD, PhD

Contact Dr. Rostami

901 Walnut Street
Suite 403
Philadelphia, PA 19107

(215) 955-8100
(215) 503-1815 fax

Most Recent Peer-reviewed Publications

  1. IL-12Rβ2 has a protective role in relapsing-remitting experimental autoimmune encephalomyelitis
  2. Apoptotic cell-treated dendritic cells induce immune tolerance by specifically inhibiting development of CD4+ effector memory T cells
  3. IL-9 signaling affects central nervous system resident cells during inflammatory stimuli
  4. Emerging immunopharmacological targets in multiple sclerosis
  5. 1,25-Dihydroxyvitamin D3 enhances neural stem cell proliferation and oligodendrocyte differentiation
  6. Analysis of 13 cell types reveals evidence for the expression of numerous novel primate- And tissue-specific microRNAs
  7. Expression of GM-CSF in T cells is increased in multiple sclerosis and suppressed by IFN-β therapy
  8. Silencing IFN-γ binding/signaling in astrocytes versus microglia leads to opposite effects on central nervous system autoimmunity
  9. c-kit plays a critical role in induction of intravenous tolerance in experimental autoimmune encephalomyelitis
  10. Mechanisms of immunological tolerance in central nervous system inflammatory demyelination
  11. Astrocyte-derived lactosylceramide implicated in multiple sclerosis
  12. Interferon regulatory factor (IRF) 3 is critical for the development of experimental autoimmune encephalomyelitis
  13. Tolerogenic dendritic cells produced by lentiviral-mediated CD40- and interleukin-23p19-specific shRNA can ameliorate experimental autoimmune encephalomyelitis by suppressing T helper type 17 cells
  14. Neurotrophin 3 transduction augments remyelinating and immunomodulatory capacity of neural stem cells
  15. DAB389IL-2 suppresses autoimmune inflammation in the CNS and inhibits T cell-mediated lysis of glial target cells
  16. Erratum: CNS-specific Therapy for Ongoing EAE by Silencing IL-17 Pathway in Astrocytes(Molecular Therapy)
  17. Immunotherapy using lipopolysaccharide-stimulated bone marrow-derived dendritic cells to treat experimental autoimmune encephalomyelitis
  18. Committed Tc17 cells are phenotypically and functionally resistant to the effects of IL-27
  19. GM-CSF in autoimmune inflammation of the central nervous system
  20. Role of Th17 cells in the pathogenesis of CNS inflammatory demyelination
0